Latest
Moderna plunges 25% after cancer vaccine trial results fail to impress
Shares of Moderna fell sharply after a Phase 3 trial of its personalized mRNA cancer vaccine met endpoints but drew muted analyst reactions. Targets remain below prior close.
BCV posts 5% profit growth as new money inflows surge
Swiss cantonal bank's half-year profit rises despite flat net interest income, with CHF 2.4 bln in new client money driving asset growth to CHF 141.8 bln.
Norse Atlantic posts $132 mln Q2 loss as revenue falls short of forecast
Airline’s second-quarter revenue of $132 million missed a $1.65 billion target, while EBITDA widened to negative $8 million. Stock near 52-week low after bridge loan repayment.
LGT posts 17% profit gain as assets top CHF400bn in H1 2026
Private bank’s net new money inflows hit CHF12.3bn, lifting managed assets to a record CHF412.6bn. CET1 ratio declines to 18.0% as costs rise 2%.
Swedish cybersecurity firm Clavister posts 63% revenue surge in Q2
Clavister Holding AB reported a sharp increase in net sales to 89 million Swedish kronor, reversing a prior-year loss as operating profit reached 13 million kronor. The company cited strong order backlog and a growing sales pipeline.
Swiss stocks rise as 19 of 20 SMI components gain; Roche leads, Aryzta slumps
The SMI advanced 0.12-0.16% with Roche up 0.52% as 19 of 20 index members gained. Aryzta tumbled over 6% after UBS downgraded it to sell amid broader market strength.
North Dakota oilfield activity rises as crude prices climb toward $80
Rig count increases to 33 in August from 27 in July as Bakken crude trades at a $4.39 premium. Operators cite sustained price strength and Middle East supply risks as drivers.
Swiss Prime Site posts 2.4% rise in H1 FFO I to CHF 2.15 per share
Swiss Prime Site reported a 2.4% increase in first-half funds from operations to CHF 2.15 per share, supported by higher rental income and asset management inflows. Full-year FFO I guidance maintained at upper end of CHF 4.25-4.30 range.
Südkorea testet Arktis-Route nach Europa trotz EU-Sanktionsrisiko
Erste Containerschiff-Pilotfahrt durch Russlands Nordostpassage soll Fahrzeit um bis zu 35% verkürzen, doch westliche Partner warnen vor Kooperation mit Moskau.
DAX rebounds above 26,000 after four-day losing streak
German blue-chip index gains 0.31% as investors reassess bond yields and corporate earnings. Fielmann, CTS Eventim, FMC shares slide on weak outlooks.
Norway's B2 Impact lifts 2026 profit target after Q2 earnings surge
Adjusted Q2 EPS rose 21% to NOK 0.66 as unsecured collections offset lower secured revenue. The firm raised its 2026 EPS forecast to NOK 2.25 and boosted investment plans to NOK 4 billion.
Starbreeze Q2 revenue falls 52% as third-party publishing exits
Swedish game developer posts SEK 25.6 million in revenue, missing estimates, as it shifts focus to the PAYDAY franchise following the end of third-party publishing.
Trader loses $24 million on ether in 12 seconds after $49 million crypto short
A Hyperliquid wallet liquidated a 50,000 ETH short position as ether's price surged, triggering a rapid loss.
BizLink posts record Q2 revenue, margins as AI demand boosts connectivity sales
Taiwan’s BizLink reported NT$23.28 billion in Q2 revenue, beating estimates by 1.7% as AI-driven demand lifted margins to record highs. Semiconductor and HPC segments drove growth.
Akastor reports NOK 17.3/share NAV in Q2 2026, dividend declared
Norwegian investment firm's adjusted NAV fell 10% sequentially as portfolio rebalancing continued. Board approved NOK 0.50 per share cash dividend for Q2.
Rapala VMC H1 2026 profit jumps 57% on North America sales surge
Fishing gear maker Rapala VMC posted a 57% rise in first-half 2026 operating profit, driven by a 19% sales jump in North America, which now accounts for 57% of group revenue.
Straumann shares drop 2.9% as Deutsche Bank cuts target, cites risks
Swiss dental-technology group Straumann fell after Deutsche Bank downgraded its rating to hold and slashed its price target by 17%, citing valuation concerns and CEO transition risks.
Siegfried shares jump 6.7% after strong H1 2026 results
Swiss pharma services firm posts CHF 633 million in revenue, beats estimates on organic growth and drug substance sales. Stock nears 52-week high.
China Evergrande founder sentenced to life in prison for fraud
Hui Ka Yan, founder of the world’s most indebted property developer, received a life sentence with asset forfeiture after eight charges including fraud and misuse of funds. Verdict delivered in Hong Kong on Thursday.
Global economic calendar: August 20, 2026 — earnings, inflation and central bank updates
AEGON, Alibaba and Walmart among companies reporting quarterly results; Germany releases producer prices and trade data alongside Sweden’s Riksbank rate decision.
Swiss corporate earnings, economic data due next week
First-half results from Swiss firms and key macro releases are scheduled for Aug. 20-27, including UBS-CFA index, Swissmem tech data and SBB H1 outlook.
Headhunter Jauch: Balancing growth and risk key to sustainable private banking
Headhunter Reto Jauch argues that Swiss private banks must blend aggressive growth with disciplined risk management, with robust governance and compliance at the core of long-term stability.
Holcim to acquire Fermacell for €840 million
Swiss cement group Holcim signed an agreement to buy European wall‑panel maker Fermacell, targeting €22 million of EBITDA synergies and an EPS boost in the first year.
Global stocks rise as U.S. bond-buyback plan eases yields; Moderna soars 177%
Swiss SMI and U.S. Dow Jones advance modestly after U.S. Treasury doubles long-dated bond purchases to calm markets. Moderna surges on melanoma-vaccine study with Merck, while Brent crude edges up 0.3% to $91.87.